Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Roth, Carina ^a   Pantel, Klaus ^a   Müller, Volkmar ^a   Rack, Brigitte ^b   Kasimir Bauer, Sabine ^c   Janni, Wolfgang ^d   Schwarzenbach, Heidi ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CASPASE 3; CASPASE 7; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; NUCLEIC ACID; PROGESTERONE RECEPTOR; PROTEINASE; PEPTIDE HYDROLASE;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BREAST CANCER; BREAST DISEASE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; NUCLEOSOME; PROTEIN DEGRADATION; ADOLESCENT; BLOOD; BREAST TUMOR; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 7; DISEASE PROGRESSION; DNA, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; NUCLEOSOMES; PEPTIDE HYDROLASES; YOUNG ADULT;

EID: 78650878367     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-4     Document Type: Article

References (37)

1. Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009, 33(5):315-318. 10.1016/j.canep.2009.10.003, 19896917.
2. Vetto JT, Luoh SW, Naik A. Breast cancer in premenopausal women. Curr Probl Surg 2009, 46(12):944-1004. 10.1067/j.cpsurg.2009.07.002, 19887229.
3. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer--a survey. Biochim Biophys Acta 2007, 1775(1):181-232.
4. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001, 313(1-2):139-142. 10.1016/S0009-8981(01)00665-9, 11694251.
5. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391(6662):43-50. 10.1038/34112, 9422506.
6. Choi JJ, Reich CF, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005, 115(1):55-62. 10.1111/j.1365-2567.2005.02130.x, 1782131, 15819697.
7. Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol 1992, 90(1):56-62. 10.1111/j.1365-2249.1992.tb05831.x, 1554541, 1395101.
8. Schwarzenbach H, Kemper B, Beeger C, Otterbach F, Kimmig R, Pantel K, S K-B. Evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res 2009,
9. Schwarzenbach H, Muller V, Beeger C, Gottberg M, Stahmann N, Pantel K. A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer. Breast Cancer Res 2007, 9(5):R66. 10.1186/bcr1772, 2242661, 17915011.
10. Schwarzenbach H, Muller V, Stahmann N, Pantel K. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Ann N Y Acad Sci 2004, 1022:25-32. 10.1196/annals.1318.005, 15251935.
11. Schwarzenbach H, Pantel K, Kemper B, Beeger C, Otterbach F, Kimmig R, Kasimir-Bauer S. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res 2009, 11(5):R71. 10.1186/bcr2404, 2790848, 19772563.
12. Holdenrieder S, Nagel D, Schalhorn A, Heinemann V, Wilkowski R, von Pawel J, Raith H, Feldmann K, Kremer AE, Muller S, et al. Clinical relevance of circulating nucleosomes in cancer. Ann N Y Acad Sci 2008, 1137:180-189. 10.1196/annals.1448.012, 18837945.
13. Deligezer U, Akisik EE, Akisik EE, Kovancilar M, Bugra D, Erten N, Holdenrieder S, Dalay N. H3K9me3/H4K20me3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer. Adv Exp Med Biol Ed Gahan P Springer 2010, 97-104.
14. Holdenrieder S, Spuler A, Tischinger M, Nagel D, Stieber P. Presence of Nucleosomes in Cerebrospinal Fluid of Glioblastoma Patients - Potential for Therapy Monitoring. Adv Exp Med Biol Ed Gahan P Springer 2010, 79-84.
15. Kohles N, Nagel D, Jüngst D, Durner J, Stieber P, Holdenrieder S. The Course of Circulating Nucleosomes in Liver Cancer Patients Undergoing Transarterial Chemoembolization Therapy. Adv Exp Med Biol Ed Gahan P Springer 2010, 73-78.
16. Stoetzer OJ, Fersching DMI, Holdenrieder S. Circulating Nucleosomes and DNAse in Breast Cancer Patients During Neoadjuvant Chemotherapy. Adv Exp Med Biol Ed Gahan P Springer 2010, 85-90.
17. Kuroi K, Tanaka C, Toi M. Plasma Nucleosome Levels in Node-Negative Breast Cancer Patients. Breast Cancer 1999, 6(4):361-364. 10.1007/BF02966454, 11091744.
18. Kuroi K, Tanaka C, Toi M. Clinical significance of plasma nucleosome levels in cancer patients. Int J Oncol 2001, 19(1):143-148.
19. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007, 7(10):800-808. 10.1038/nrc2228, 17851543.
20. Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 2006, 5(9):785-799. 10.1038/nrd2092, 16955069.
21. Soini Y, Paakko P, Lehto VP. Histopathological evaluation of apoptosis in cancer. Am J Pathol 1998, 153(4):1041-1053. 1853067, 9777936.
22. Vakkala M, Paakko P, Soini Y. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 1999, 81(4):592-599. 10.1038/sj.bjc.6690735, 2362889, 10574243.
23. Deligezer U, Erten N, Akisik EE, Dalay N. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma. Exp Mol Pathol 2006, 80(1):72-76.
24. Friedl P, Wolf K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res 2008, 68(18):7247-7249. 10.1158/0008-5472.CAN-08-0784, 18794108.
25. Aimes RT, Zijlstra A, Hooper JD, Ogbourne SM, Sit ML, Fuchs S, Gotley DC, Quigley JP, Antalis TM. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost 2003, 89(3):561-572.
26. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009, 6(6):339-351. 10.1038/nrclinonc.2009.44, 19399023.
27. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4(6):448-456. 10.1038/nrc1370, 15170447.
28. Schwarzenbach H, Alix-Panabieres C, Muller I, Letang N, Vendrell JP, Rebillard X, Pantel K. Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer. Clin Cancer Res 2009, 15(3):1032-1038. 10.1158/1078-0432.CCR-08-1910, 19188176.
29. Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008, 40(6-7):1362-1378. 10.1016/j.biocel.2007.12.006, 18258475.
30. Hemsen A, Riethdorf L, Brunner N, Berger J, Ebel S, Thomssen C, Janicke F, Pantel K. Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells. Int J Cancer 2003, 107(6):903-909. 10.1002/ijc.11488, 14601049.
31. Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F, Xu XC. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 2008, 122(9):2050-2056. 10.1002/ijc.23337, 18172859.
32. Jiang N, Pisetsky DS. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J Leukoc Biol 2005, 77(3):296-302. 10.1189/jlb.0704411, 15601668.
33. Zanetti-Dallenbach RA, Schmid S, Wight E, Holzgreve W, Ladewing A, Hahn S, Zhong XY. Levels of circulating cell-free serum DNA in benign and malignant breast lesions. Int J Biol Markers 2007, 22(2):95-99.
34. Schubbert R, Lettmann C, Doerfler W. Ingested foreign (phage M13) DNA survives transiently in the gastrointestinal tract and enters the bloodstream of mice. Mol Gen Genet 1994, 242(5):495-504. 10.1007/BF00285273, 8121408.
35. Holdenrieder S, von Pawel J, Dankelmann E, Duell T, Faderl B, Markus A, Siakavara M, Wagner H, Feldmann K, Hoffmann H, et al. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Clin Cancer Res 2008, 14(23):7813-7821. 10.1158/1078-0432.CCR-08-0678, 19047109.
36. Kim MJ, Park BW, Lim JB, Kim HS, Kwak JY, Kim SJ, Park SH, Sohn YM, Moon HJ, Kim EK. Axillary lymph node metastasis: CA-15-3 and carcinoembryonic antigen concentrations in fine-needle aspirates for preoperative diagnosis in patients with breast cancer. Radiology 2010, 254(3):691-697. 10.1148/radiol.09091031, 20123899.
37. Zeiwar MM, Zaki SM, Mohammad LA, Zidan AA, El Nagar MR. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients. Egypt J Immunol 2007, 14(2):29-41.